STUDY ON ANTI-OSTEOSARCOMA ACTIVITY OF ETHANOL EXTRACT OF VENENUM BUFONIS IN VITRO by Chen, Guangxing et al.
Chen et al., Afr J Tradit Complement Altern Med. (2014) 11(1):73-77
http://dx.doi.org/10.4314/ajtcam.v11i1.10
73
STUDY ON ANTI-OSTEOSARCOMA ACTIVITY OF ETHANOL EXTRACT OF VENENUM BUFONIS IN VITRO
Guangxing Chen1, Xuefeng Jiang2*, Jingyi Li3, Guangjie Duan2, Liu Yang1, Ying Zhang1, Fuyou Wang1
1Center for Joint Surgery, Southwest Hospital, Chongqing, 400038, China; 2Institute of Pathology and Southwest
Cancer Center, Third Military Medical University, Chongqing, 400038, China; 3Department of Integrative Medicine,
Southwest Hospital, Chongqing, 400038, China
*E-mail: yxwbwyc@163.com
Abstract
Background: Venenum bufonis is the dried white secretion of the auricular and skin glands of Bufo gargarizans Cantor, or Bufo melanostictus
Schneider, Bufonidae. It is used in the treatment of deep-rooted carbuncle, boils and swelling; pain in the throat, heart stroke, coma, abdominal
pain, vomiting and diarrhea. The objective of this paper is to preliminarily observe the effects of ethanol extract of Venenum bufonis on growth,
and proliferation of human osteosarcoma U2OS cell lines, and to provide a theoretical basis for an in-depth study of the clinical application of
Venenum bufonis for osteosarcoma inhibition, with its mechanism of action.
Materials and Methods: SRB assay was used to determine the effect of Venenum bufonis ethanol extract on U2OS cell line activity, and to
detect its inhibitory dose-effect on osteosarcoma cells. FCM was applied to determine the effect of Venenum bufonis ethanol extract on U2OS cell
apoptosis and to perform cell cycle analysis.
Results: As results, different Venenum bufonis ethanol extracts showed apparent concentration-effect relationships on U2OS cell lines. FCM
analysis showed that it had a U2OS apoptosis promoting effect, which increased with increasing concentration. Cell cycle analysis revealed that
the Venenum bufonis ethanol extract mainly arrested U2OS in the G0/G1 phase, preventing the cells from progressing to the S phase.
Conclusion: The study concluded that Venenum bufonis ethanol extract has an inhibitory effect on proliferation of osteosarcoma U2OS cells.
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Introduction
Osteosarcoma, also known as the osteogenic sarcoma, is the most common primary malignancy of bone tissue, which is derived from the
mesenchymal tissue, and where osteoid tissue, and immature bone tissue are produced directly by malignant cells (Xu et al., 2001). It mostly
occurs in adolescents, with its biological behavior as generally high-grade, and is prone to hematogenous metastasis in early stage. Before 1970,
the standard treatment was amputation, but the five-year survival rate was around 10%. Over the past 25, years, with the wide application of
neoadjuvant chemotherapy, and the improvement of operational methods, the five-year survival rate of osteosarcoma has reached 80%, but there
is a considerable number of patients who died of pulmonary metastases in advanced stage (Bielack et al., 2002; Szendroi et al., 2000; Kandioler et
al., 1998; Thompson et al., 2002). At present, it is believed internationally that the breakthrough on the improvement of the five-year, survival rate
of patients with osteosarcoma is difficult with existing chemotherapy regimens (Marina et al., 2004). Moreover, due to the significant toxic, and
side effects of chemotherapy, its wide application and efficacy is greatly limited. From the point of view of tumor treatment, Chinese medicines
with significant curative effect and little side effects are attracting much attention. On the one hand, Chinese medicines can eliminate tumors;
conversely, they can adjust systemic conditions of osteosarcoma patients, correct internal organ dysfunction, enhance the effect of chemotherapy
and surgery, mitigate adverse reactions of chemo-radiotherapy, and enhance the patients' immune function, thereby improving the quality of life,
with an improved survival rate.
Venenum bufonis is the dried white secretion of the auricular and skin glands of Bufo gargarizans Cantor or Bufo melanostictus Schneider,
Bufonidae. It is mainly produced in China's Hebei, Shandong, Jiangsu and Zhejiang provinces. It is warm in nature, bitter and pungent in taste,
and enters the heart meridian, with the effects of detoxification, pain relief and resuscitation induction. It is used in the treatment of deep-rooted
carbuncle, boils, swelling and pain in the throat, heart stroke, coma, abdominal pain, vomiting and diarrhea. Recent studies have shown that
Venenum bufonis not only ease pain, diminish inflammation, and is used in anesthesia, but also has multiple biological activities such as
anti-cancer, anti-radiation and cardiotonic actions (Dong et al., 2003). Due to the definite pharmacological activity of Venenum bufonis in the
clinical treatment of cancer, it has attracted widespread recognition. In this experiment, the effects of ethanol extract of Venenum bufonis on
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growth, and proliferation of human osteosarcoma U2OS cell lines were preliminarily observed, thus providing a theoretical basis for in-depth
study of the clinical application of Venenum bufonis for osteosarcoma inhibition and its mechanism of action.
Materials and Methods
Drugs and reagents
Venenum bufonis identified by professor Liu Yishan of the Shandong University of Traditional Chinese Medicine (purchased from the
Nepstar Chain Drugstore Ltd.); DMEM medium (GIBCOBRL); fluorouracil (Hengrui Medicine Co., Ltd., Jiangsu); Sulforhodamine B (SRB)
(Sigma); other reagents were all of analytical grade.
Main instruments and Materials
AE31, inverted phase contrast microscope (Motic); SW-CJ-IF clean bench (Suzhou Purification Equipment Factory); fully automatic
micro-plate reader (Mod550, BioRad, USA); low-temperature refrigerated centrifuge (Eppendorf, Germany); electronic balance (Sartorius AG,
Beijing); blood counting chamber (Qiujing Biochemical Instrument Factory, Shanghai). Human osteosarcoma cell line U2OS. Was provided by
the Department of Pharmacology of our College.
Preparation of Venenum bufonis extract
Dried Venenum bufonis material was crushed, and an appropriate amount weighed; a 25-fold amount of 70% ethanol was
added, and soaked for 30min., then ultrasonically extracted three times, [each time lasted 30min]. The extracts were combined,
ethanol removed, and the remaining was concentrated at low-temperature, and freeze-dried to get the Venenum bufonis extract powder.
When it was ready for use, the right amount of powder was accurately weighed, and diluted with culture medium to the desired
concentration.
Cell cultivation
The proliferating cells in the logarithmic growth phase were dispersed with 0.25%, trypsin-EDTA, and then counted. It was prepared into
cell suspension, and seeded in a 96-well plate at 180μL/well, after pre-incubation for 24hrs, each well was added with 20μL of drug (final 
concentration of 1/10, of the prepared concentration), total liquid volume of each well was 200μL, six replicate wells were set up for each drug 
concentration, and blank control group was set up as well, the plates were placed in an 37 ℃, 5% CO2 incubator, and cultured under full wet
conditions for 48hrs.
Detection of Anticancer Sensitivity by SRB, colorimetric assay
With reference to the Skehan’s method in (Skehan et al., 1990), after the completion of cell culture, each well was added with 50μL, of 
50%, trichloroacetic acid (TCA), to fix the cells. The final concentration of TCA was 10%, which was gently added to the liquid surface of each
well, and then the plate was placed in a 4℃, refrigerator for 1hr. Each well of the culture plate was washed with deionized water, five times to
remove TCA. After drying in air, each well was added with 100μL, of 0.4%, SRB, and allowed to stand at room temperature for 10~30min. 
Liquid in each well was discarded, and unbound dye was removed by five washes with 1% acetate, after drying in air, the remaining was
dissolved with 10mmol/L unbuffered Tris base (Tris (hydroxymethyl), amino methane), with a pH of 10.5, then oscillated in an oscillator for
5min, and OD value was measured at a wavelength of 490nm, in a microplate reader using the value of blank control for zero adjustment. The
obtained tumor cell growth inhibition rate was defined as the in vitro inhibition rate of the drug on tumor cells.
Tumor inhibition rate (%) = (OD value of drug-free cell control well - OD value of drug well), / OD value of drug-free cell control well ×
100%.
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Colony forming assays (Yin et al., 2008)
U2OS cells were seeded in 10mL culture dishes at 100, cells/dish, and cultured for 24hrs. Venenum bufonis ethanol extract was added to
make the concentration 25.0, 50.0, 100, and 200mg/L respectively. Blank control group, and 5-Fu group (50 mg/L), were also set up, and
cultivation was further continued for 10 days. Culture solution was discarded, cells were rinsed trice with PBS, and fixed with 10% methanol,
15min., later, fixative was discarded, and cells were stained with 0.25%, gentian violet. Number of colonies greater than 50, cells was counted
under a microscope, and the rate of colony formation was calculated.
Colony formation rate (%) = number of colonies / number of seeded cells × 100%.
Flow cytometry (FCM) analysis (Yin et al., 2004)
U2OS cells treated with different drug concentrations were collected, with each group containing approximately 1×105 cells, and fixed
with 70% cold ethanol at 4℃, overnight, washed twice with PBS, digested at 37℃, with lmg/ml RNase A (Sigma) for 30min., stained with
100μg/ml propidium iodide for 20min., then cell ratio, and apoptosis rate of each phase under the action of different concentrations of drug were 
determined by FCM.
Statistical methods
The data were analyzed using SPSS 13.0 software, and comparisons between two groups were performed by t-test, while pairwise
comparisons among groups were performed using one-way ANOVA.
Results
SRB colorimetric assay
The activity of human osteosarcoma U2OS cells after treatment with different concentrations of Venenum bufonis ethanol extracts that
were short-term cultured in a 96-well culture plate was studied, and the results are shown in Fig.1. When human osteosarcoma U2OS cell lines
were between 6×104cells/mL, to 1×106cells/mL, with the increase in the number of cells, OD values obtained by SRB assay also increased. The
inhibitory effect of Venenum bufonis ethanol extract on U2OS cells presented a certain dose-effect relationship. The greater the concentration of
the extracts, the higher the inhibition rate.
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Figure 1: Dose-effect curve of Venenum bufonis extract on U2OS
Colony forming assay results
The effects of different doses of Venenum bufonis ethanol extracts on U2OS colony formation are shown in Tab. 1. As shown [Table. 1],
five Venenum Bufonis ethanol extract dose groups all had different degrees of inhibitory effects on colony formation of U2OS cell lines, and the
differences were all significant when each dose group was compared with the blank control group.
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Flow cytometry (FCM) analysis results
FCM analysis results are as shown in Table 2, compared with the blank control group, after induction of cells by different concentrations of
Venenum bufonis ethanol extracts, in the G0/G1 phase, cells increased with the increase of drug concentration, changes were not evident in the S
phase, which were around the levels of 100mg/L to 200mg/L, in the G2/M phase, cells were significantly reduced, indicating that the cells may
mainly be arrested in the G0/G1 phase. Apoptosis rate increased significantly with increasing concentration.
Table 1: Inhibitory effect of Venenum bufonis ethanol extract on U2OS colony formation
Group Concentration (mg/L) Colony formation rate (%)
Blank control group - 96.8±1.3
5-Fu group 50 79.1±3.6
Venenum Bufonis ethanol extract 1 12.5 90.3±4.1
Venenum Bufonis ethanol extract 2 25 89.4±2.7
Venenum Bufonis ethanol extract 3 50 85.5±4.8
Venenum Bufonis ethanol extract 4 100 82.8±3.1
Venenum Bufonis ethanol extract 5 200 80.2±3.2
Note: comparison of each dose group with the blank control group, P<0.05.
Table 2: Percentage of each cycle after induction of U2OS cells by different concentrations of Venenum bufonis extracts for 48 h (%)
Concentration (mg/
L)
G0/G1 phase S phase G2/M phase Apoptosis rate
0 43.78±3.6 38.87±2.1 17.27±0.9 2.2±1.1
50 51.28±4.7 29.67±3.2 20.11±2.7 8.9±2.5
100 57.43±5.5 36.28±4.1 6.3±1.8* 28.2±4.8*
200 62.27±5.2 31.92± 5.97±1.3* 33.7±5.6*
Comparison with the blank control group: "*" indicates P<0.05
Discussion
The in vitro assay of tumor inhibitory effect of anticancer drugs have significant values in these aspects such as screening of effective
anti-cancer drugs, assisting in estimation of anticancer spectrum of anti-cancer drugs, and individualization of clinical treatment with anti-cancer
drugs. Among various methods, comparatively speaking, MTT is simple, sensitive, rapid, and semi-automated, which is considered to be of good
practical value, it is also a method widely used at present. As for SRB assay, a new method for screening of anticancer drugs by NCI, the time
required for experimental operation is even shorter compared with MTT. TCA cell fixation needs 1hr, and SRB staining only needs 10~30min.,
whereas, in the MTT assay, after cells were added to MTT, an additional 4hrs is needed. SRB assay is more sensitive than the MTT assay, if there
are only 150, cells in a well, inhibition rate can be detected by SRB assay, while MTT assay can’t (Haselsberger et al., 1996).
We found through the study of Venenum bufonis ethanol extract that, it has an apparent inhibitory effect on growth of osteosarcoma U2OS
cell lines. The effect of the drug on cell viability is investigated by SRB assay, and colony formation assay, and it was found that different
Venenum bufonis ethanol extracts all showed apparent concentration-effect relationships on U2OS cell lines. FCM analysis showed that the
extract had a U2OS apoptosis promoting effect, which increased with increasing concentration. Cell cycle analysis found that the Venenum
bufonis ethanol extract mainly arrested U2OS, in the G0/G1 phase, preventing them from progressing to the S phase.
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